FRLN
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Biological Product (except Diagnostic) Manufacturing
Biotechnology
Health Technology
Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
No additional data available
Earnings History
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
Tags
Biological Product (except Diagnostic) Manufacturing
Biotechnology
Health Technology
Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
No additional data available
Earnings History
CEO
Michael J. Parini
Location
N/A, United Kingdom
Exchange
Nasdaq
Website
https://www.freeline.life
Description
Freeline Therapeutics Holdings plc develops transformative adeno-associated virus (AAV) vector-mediated gene therapies.
CEO
Michael J. Parini
Location
N/A, United Kingdom
Exchange
Nasdaq
Website
https://www.freeline.life
Description
Freeline Therapeutics Holdings plc develops transformative adeno-associated virus (AAV) vector-mediated gene therapies.